Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05288738
Other study ID # FF-2019-543
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 9, 2019
Est. completion date January 10, 2021

Study information

Verified date April 2021
Source Universiti Kebangsaan Malaysia Medical Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PCA morphine have been a common method in providing excellent analgesia for post-operative period. However, the usage of morphine is not without any side effects such as nausea, vomiting, respiratory depression, and over sedation. Many adjunct have been used in combination with morphine to observe the opioid sparing effects at the same time providing good analgesia. Dexmedetomidine is a potent and selective alpha-2 receptor agonist with sedative, anxiolytic, sympatholytic, and analgesic effects. As dexmedetomidine and morphine act via different mechanism, this combination produces synergistic analgesic effects. The objective of our study was to observe the effectiveness in pain relief between two low concentration of dexmedetomidine (2 mcg/ml versus 1 mcg/ml) as an adjunct to PCA morphine 1 mg/ml.


Description:

This was a double-blinded prospective randomised study conducted in Universiti Kebangsaan Malaysia Medical Centre from January 2020 till November 2020. This study was approved by Dissertation Committee of the Department of Anaesthesiology and Intensive Care, Universiti Kebangsaan Malaysia Medical Centre (UKMMC) and Medical Research and Ethics Committee of UKMMC. Consent was taken during preoperative visit whereby patients were counselled on the use of PCA machine and assessment of pain score using visual analogue scale (VAS). All patients were not given sedative premedication before surgery. Induction of general anaesthesia was with IV fentanyl 2 mcg/kg, IV propofol 2 mg/kg and paralysed with IV rocuronium 0.6 mg/kg. Patients were given IV dexamethasone 0.2 mg/kg for postoperative nausea and vomiting (PONV) prophylaxis. Anaesthesia was maintained with sevoflurane to achieve MAC of 1.0 with oxygen and air in 1:1 ratio. All patients received IV morphine 0.1mg/kg intraoperatively, and surgical site infiltrated with levobupivacaine 0.5% 2 mg/kg. IV granisetron 1 mg was given to all patients at the end of the surgery and reversal was with IV neostigmine 0.05 mg/kg and IV atropine 0.02 mg/kg. All patients were connected to the PCA morphine with test drugs after arrival in the recovery area. Patients were encouraged to self-administer the PCA whenever required. In an event of uncontrolled pain, rescue analgesia was with IV fentanyl 20 mcg boluses. All patients upon discharged to ward from recovery bay must have pain score (VAS) of less than 4, respiratory rate more than 10, MAP > 65 mmHg and HR > 60 beats/minute. Patients were followed up at 6, 12, and 24 hours after surgery to look at the cumulative PCA morphine usage, incidence of nausea and vomiting, sedation score, respiratory depression (respiratory rate < 10 breath/min/). Side effects from dexmedetomidine namely hypotension (MAP < 65) and bradycardia (HR < 60) were also documented. The severity of nausea and vomiting was defined as mild, moderate, or severe while sedation was assessed according to five levels: 0, 1, 2, 3 and 4. The power calculation for this study was based on a pilot study observing PCA consumption in the first 24 hours after surgery, with a mean difference, 14.67 and pooled standard deviation 20.27 in regard to dosage delivered comparing PCA morphine with dexmedetomidine 1 mcg/ml to PCA morphine with dexmedetomidine 2 mcg/ml. A group of 34 subjects each would be needed for a study with an alpha level of 0.05 (two-tailed) and a beta level of 0.2 (80% power) including 10% dropout rate. Data were analysed using IBMR SPSSRs Statistics MacOS version 26.0 (IBM Corporation, New York, United States of America). The results were presented as frequency (percentage) and standard deviation whenever appropriate. The cumulative PCA morphine and dexmedetomidine usage pain score was analysed using the Mann-Whitney U-test. The incidence of sedation and PONV was analysed using Chi-square. Heart rate and blood pressure were analysed using independent T-test. A probability level of < 0.05 was considered to be statistically significant.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date January 10, 2021
Est. primary completion date December 8, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - ASA 1 & 2 patient - going for elective or emergency laparotomy surgery Exclusion Criteria: - patient with known allergy to morphine or dexmedetomidine - Creatinine clearance less then 30ml/min - Current alcohol dependency - Psychiatric illness on regular sedative-hypnotic drugs - significant obstructive sleep apnoea (OSA) - Chronic pain patient who on regular opioids

Study Design


Intervention

Drug:
Dexmedetomidine 1 mcg/ml
34 patients received PCA morphine 1 mg/ml with combination of dexmedetomidine 1 mcg/ml
Dexmedetomidine 2 mcg/ml
34 patients received PCA morphine 1 mg/ml with combination of dexmedetomidine 2 mcg/ml

Locations

Country Name City State
Malaysia Universiti Kebangsaan Malaysia Medical Center Cheras Kuala Lumpur

Sponsors (1)

Lead Sponsor Collaborator
Universiti Kebangsaan Malaysia Medical Centre

Country where clinical trial is conducted

Malaysia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total morphine consumption Measure the total PCA morphine (mg) consumption post laparotomy 24 hours
Secondary Morphine side effects Assess the frequency and severity of morphine side effects with the use of PCA morphine post laparotomy (PONV, over sedation, respiratory depression) at 6, 12, and 24 hours post laparotomy
Secondary Analgesic effects Assess patient's pain score post laparotomy at 6, 12, and 24 hours post laparotomy
Secondary Dexmedetomidine side effects Assess frequency and severity of dexmedetomidine side effects (hypotension, bradycardia) at 6, 12, and 24 hours post laparotomy
See also
  Status Clinical Trial Phase
Terminated NCT02747875 - Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery N/A
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Completed NCT02244099 - Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic N/A
Recruiting NCT03923374 - Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Completed NCT04069403 - An Opioid Prescribing Nudge N/A
Completed NCT04155229 - EMR Defaults to Nudge Opioid Prescribing N/A
Completed NCT02299024 - Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter N/A
Recruiting NCT04564729 - Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing N/A
Recruiting NCT05283980 - Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement Phase 2/Phase 3
Completed NCT04854551 - Opioid Modulation and Neural Reward Activation in Healthy Adults Phase 1/Phase 2
Recruiting NCT06050551 - Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery N/A
Completed NCT04928339 - Pecto-Intercostal Fascial Plane Block Study Phase 4
Completed NCT03773484 - Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase N/A
Completed NCT02653144 - the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block Phase 4
Enrolling by invitation NCT05875857 - Patient Utilization of Opioid Destruction Bags in the Post op Period N/A
Recruiting NCT04275258 - Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder N/A
Completed NCT04252443 - Nurses' Knowledge and Attitude About Opioids N/A
Recruiting NCT05242081 - Study on Opioid-free Anesthesia Protocol With S-ketamine and Propofol N/A
Completed NCT02431793 - EHR‐Based Medication Complete Communication Strategy to Promote Safe Opioid Use N/A
Completed NCT03959969 - Educational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery N/A